A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This open-label study will evaluate the safety, tolerability, pharmacokinetics and effect on
tumor growth following a single intralesional injection of PV-10 in subjects with either (a)
hepatocellular carcinoma (HCC) that is not amenable to resection, transplant or other
potentially curative therapy or (b) cancer metastatic to the liver.